Exploring the Proteomic Landscape of Cochlear Implant Trauma: An iTRAQ-Based Quantitative Analysis Utilizing an Ex Vivo Model
Authors:
- Jake LanglieJLJake Langlie
- Rahul MittalRahul Mittal
- David H. ElishaDEDavid H. Elisha
- Jaimee CooperJCJaimee Cooper
- Hannah MarwedeHMHannah Marwede
- Julian PurrinosJPJulian Purrinos
- Maria-Pia TusetMTMaria-Pia Tuset
- Keelin McKennaKMKeelin McKenna
- Max ZaltaMZMax Zalta
- Jeenu MittalJMJeenu Mittal
- Adrien A. EshraghiAdrien A. Eshraghi
Open Access
- 18 July 2025
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (14) , 5115
Abstract
Background: Cochlear implantation is widely used to provide auditory rehabilitation to individuals with severe-to-profound sensorineural hearing loss. However, electrode insertion during cochlear implantation leads to inner ear trauma, damage to sensory structures, and consequently, loss of residual hearing. There is very limited information regarding the target proteins involved in electrode insertion trauma (EIT) following cochlear implantation. Methods: The aim of our study was to identify target proteins and host molecular pathways involved in cochlear damage following EIT utilizing the iTRAQ™ (isobaric tags for relative and absolute quantification) technique using our ex vivo model. The organ of Corti (OC) explants were dissected from postnatal day 3 rats and subjected to EIT or left untreated (control). The proteins were extracted, labelled, and subjected to ultra-high performance liquid chromatography–tandem mass spectrometry. Results: We identified distinct molecular pathways involved in EIT-induced cochlear damage. Confocal microscopy confirmed the expression of these identified proteins in OC explants subjected to EIT. By separating the apical, middle, and basal cochlear turns, we deciphered a topographic array of host molecular pathways that extend from the base to the apex of the cochlea, which are activated post-trauma following cochlear implantation. Conclusions: The identification of target proteins involved in cochlear damage will provide novel therapeutic targets for the development of effective treatment modalities for the preservation of residual hearing in implanted individuals.Keywords
This publication has 67 references indexed in Scilit:
- Identify of blood glucose metabolism regulation pathways and related proteins in the db/db mouse model through iTRAQ quantitative mass spectrometryActa Diabetologica, 2025
- Orosomucoid 2 as a biomarker of carotid artery atherosclerosis plaque vulnerability through its generation of reactive oxygen species and lipid accumulation in vascular smooth muscle cellsBiochemical and Biophysical Research Communications, 2024
- Research progress in the application of proteomics technology in brain injuryBiomedical Chromatography, 2023
- Proteomics approaches to characterize the immune responses in cancerBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2022
- Long‐term cochlear implantation outcomes in patients following head injuryLaryngoscope Investigative Otolaryngology, 2020
- Quantitative Proteomic Analysis of Human Aqueous Humor Using iTRAQ 4plex Labeling2017
- Usher syndrome: Hearing loss, retinal degeneration and associated abnormalitiesBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2015
- The Cochlear Implant: Historical Aspects and Future ProspectsThe Anatomical Record, 2012
- A Novel Organ of Corti Explant Model for the Study of Cochlear Implantation TraumaThe Anatomical Record, 2012
- Combined acoustic and electric hearing: Preserving residual acoustic hearingHearing Research, 2008